US equities |
SPCX $167.52 ▲+5.39% NVDA $236.28 ▲+0.99% MU $1,066.29 ▼-0.80% TSLA $378.44 ▲+2.12% MSFT $526.43 ▲+1.72% SNDK $1,710.00 ▼-0.58% INTC $117.28 ▼-1.72% META $744.74 ▲+2.29%
FinancialContent

Articles published by Seres Therapeutics

News headline image
Seres Therapeutics to Present at Chardan Metagenomics and Microbiome Medicines Summit
From Seres Therapeutics
Via Business Wire
Tickers MCRB
News headline image
Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a Potential Treatment Against Recurrent C. difficile Infection
From Seres Therapeutics
Via Business Wire
Tickers MCRB